Medium-term comprehensive outcomes of heart transplantation using donors with hepatitis C viremia to aviremic recipients
Open Access
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current EraJournal of Cardiac Failure, 2023
- Outcomes of Over 1000 Heart Transplants Using Hepatitis C–Positive Donors in the Modern EraThe Annals of Thoracic Surgery, 2022
- The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative RecipientsClinics in Liver Disease, 2022
- HCV-Positive Allograft Use in Heart Transplantation Is Associated With Increased Access to Overdose Donors and Reduced Waitlist Mortality Without Compromising OutcomesJournal of Cardiac Failure, 2022
- Hepatitis C Positive Organ Donation in Heart TransplantationCurrent Transplantation Reports, 2021
- Liver Transplantation Using Hepatitis C Virus–Viremic Donors Into Hepatitis C Virus–Aviremic Recipients as Standard of CareLiver Transplantation, 2020
- Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis CJAMA Cardiology, 2020
- The rise of the opioid epidemic and hepatitis C–positive organs: A new era in liver transplantationHepatology, 2018
- Hepatitis C in Transplant Recipients of Solid Organs, Other than LiverClinics in Liver Disease, 2006
- Hepatitis C Virus Seropositivity in Organ Donors and Survival in Heart Transplant RecipientsJAMA, 2006